From clinical trials to product recalls, a new company-wide framework will ensure the voice of the patient is heard across Medtronic PLC’s premarket and postmarket activities.
“We are in the midst of investing [in] and developing a more comprehensive, systematic approach to receiving patient input along the range of activities that we have, whether it’s in clinical trials or whether it’s in patients who have already been treated